The Evolving Treatment Landscape in Multiple Myeloma: An Expert Case-Based Discussion

home / peer-exchange / the-evolving-treatment-landscape-in-multiple-myeloma-an-expert-case-based-discussion

Sponsored in part by Amgen Oncology and Sanofi. Content independently created by OncLive.

Joseph Mikhael, MD, and panelists present a case of a 63-year-old woman with early relapse multiple myeloma and discuss the impact of updated trial data on treatment decision-making for patients.

Experts on MM

EP. 1: Frontline Therapy in Multiple Myeloma

December 22nd 2022

Joseph Mikhael, MD, discusses diagnosis criteria and treatment considerations for patients with multiple myeloma in the frontline setting.

Expert on MM

EP. 2: Case Study: Myeloma at Early Relapse

January 5th 2023

Dr Joseph Mikhael and expert panel review a case study in early relapse multiple myeloma and the impact of cytogenetics in risk assessment for patients with early relapse multiple myeloma.

Expert on MM

EP. 3: Treatment Options in Early Relapse Multiple Myeloma

January 5th 2023

Dr Joseph Mikhael and expert panel review current treatment options for patients with early relapse multiple myeloma, in accordance with current NCCN guidelines.

Expert on MM

EP. 4: Clinical Trials in R/R Multiple Myeloma

January 12th 2023

Dr Joseph Mikhael and expert panel discuss key efficacy and safety outcomes of pivotal clinical trials evaluating treatment regimens in patients with R/R multiple myeloma.

Expert on MM

EP. 5: Final Thoughts on Case Study and Treating Multiple Myeloma

January 12th 2023

Dr Joseph Mikhael and expert panel re-visit the patient case and offer their final thoughts on the impact of clinical trial updates in the treatment landscape of multiple myeloma.